Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies - Wikidata - awgldk - TriplyDB

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies

http://www.wikidata.org/entity/Q35185997

about

Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques Prospects for developing an effective particle-mediated DNA vaccine against influenza.Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques.Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.HIV-1 vaccine development after STEP.Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239 T-cell immune responses against Env from CRF12_BF and subtype B HIV-1 show high clade-specificity that can be overridden by multiclade immunizations Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges A model for testing the immunogenicity of simian immunodeficiency virus and simian-human immunodeficiency virus vaccine candidates in mice.Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice.Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors.Schistosoma mansoni soluble egg antigens enhance T cell responses to a newly identified HIV-1 Gag H-2b epitope Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen.Vitamin A deficiency impairs vaccine-elicited gastrointestinal immunity.Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling.HIV DNA Vaccine: Stepwise Improvements Make a Difference.Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization Memory CD8+ T cells specific for a single immunodominant or subdominant determinant induced by peptide-dendritic cell immunization protect from an acute lethal viral disease.Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition.Engineering recombinant reoviruses with tandem repeats and a tetravirus 2A-like element for exogenous polypeptide expression Enhancement of DNA tumor vaccine efficacy by gene gun-mediated codelivery of threshold amounts of plasmid-encoded helper antigen.CD8+ T-cell cross-competition is governed by peptide-MHC class I stability Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection.Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4+ T cell responses that impair CD8+ T cell function.The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy.Theoretical aspects of immunity.Bioinformatics for cancer immunotherapy target discovery.Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation.Conserved HIV-1 Gag p24 Epitopes Elicit Cellular Immune Responses That Impact Disease Outcome.Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions.Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection.Controlling influenza by cytotoxic T-cells: calling for help from destroyers.DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling time.Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination.Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors.

P2860

Q27319783-3AAFA8DA-0A35-4851-A73C-9C6458AEEC71 Q30380300-E97297B1-2543-478C-8E0A-34157B0FD384 Q31148797-CBB4A043-53E3-4154-B9BB-7BA8328CDBBB Q33630150-D666B1E7-49FD-495A-896B-5D7D0045B11E Q33642318-22C380A8-A64A-4789-ADD0-F441258D89C0 Q33744109-03CF80EF-EDA2-476D-85F0-F5A16B30007E Q33833624-42F00916-273F-4EF2-86BE-D39561DBD45E Q33916635-26B3422D-64F8-444B-B679-F2D1546EE6AE Q34034274-E0D1FD3B-A24D-43D5-9C23-75D247937E45 Q34457800-8871EE7E-0E94-48A7-A604-56497DD6B6FC Q34653619-11F62C0F-C1B9-47AE-844B-0C9C79D48BFE Q34991437-B321950B-57EA-45F7-843F-9CC193AB2825 Q35021109-5B756849-D568-4D63-9BEE-0EBF6B138A8E Q35038794-0AF9A16F-868B-4D07-8C82-781C3B40A698 Q35147685-1C84FB01-C1A3-4C4C-8EF4-EC1277A0B646 Q35183935-C972D91A-B31D-41BE-9332-962A571BBC1C Q35826742-C2AFE2C7-2EA6-4DF6-8978-0E489D9C592F Q35857420-F904741C-DC02-4A49-9B4C-B1E6C0244F1D Q36016455-E2F1F531-3388-4B57-B6D7-F4E85E8D8202 Q36149102-DFBA7664-EE59-4DDB-9A29-9A0DED01C431 Q36211653-F25960AE-8231-409D-AF9D-86AC5F9F67C6 Q36246319-F43C6395-1234-4F0B-854D-0477D2DEEB05 Q36674446-75DE5C07-1F5B-4C45-AA46-B25E759977DD Q36756865-F0E9C18B-846C-42F7-A0E8-D00B4538C4AB Q36855368-3DFED60D-F6AA-475B-AC9C-B9C97EA4587C Q37039140-46349F8C-21F5-4EC8-9F9A-DD8CF4760755 Q37098207-2964039B-AD82-4A09-823B-A5911E03F1F2 Q37156309-34491A54-248F-4567-82EE-76751D99AEAF Q37661779-22557083-816D-4860-A22F-388E39D9D5A5 Q37729321-7A7EA470-8330-4D48-A756-F2484EA585AA Q37995258-3B86235B-0A91-481F-B794-1C8AE9783B1E Q38262688-AFD96616-E5BE-49AA-8EC2-BA0261662D7F Q38610641-6C9F12E6-62C5-47AD-9302-5144D3C27A1C Q38736699-2ED7D902-5194-4CD1-8169-1A494F8E5A51 Q40319132-95C3789E-4A43-40CC-A4CD-A4C325DE42EF Q40320327-53B2E3B0-F970-4F51-B070-14A6BCA62ADF Q40730765-F1C2BFF8-93E5-4542-8038-A5B9A25E38A6 Q41325762-7C951C54-9150-4404-9400-000486F063D5 Q43244982-E34F6190-D832-466B-B339-414F892C1434 Q47558367-CF770357-C5F5-4583-AF81-A0F564AE4AE1

P2860

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies

http://www.wikidata.org/entity/Q35185997

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies

@ast

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies

@en

type

label

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies

@ast

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies

@en

prefLabel

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies

@ast

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies

@en

P1433

Q35185997-4DE1D5E2-7135-4151-8DD4-B4036637A7E5

P1476

Q35185997-28C0FDE3-7BF4-4D24-9E7E-30A78FE4EAC5

P2093

Q35185997-24328B9F-8FAE-464B-9271-6A264EDEF55E

Q35185997-8F9DE964-A9D2-46B7-9C71-B0C4156AE1AC

Q35185997-950A2C47-5696-4CC8-A37A-1905C3BA2779

Q35185997-A17F9433-8E49-45B1-B80C-A18F6DAD9EE0

Q35185997-FDA9047A-636E-4B3D-A7BB-8D79BBD4F785

P2860

Q35185997-27CBEDE7-00DE-416E-8CEA-FDA918BDF42B

Q35185997-33B2626C-338B-4459-9E42-8A2B2C51064F

Q35185997-34755287-EE25-41B5-B1B0-E704F487B87A

Q35185997-35C8193B-4D94-4ECE-83C0-FCAA7D0A9C42

Q35185997-408AE51A-3FAA-4CB7-B4B8-66E0A8E27DF2

Q35185997-425BE046-18A6-4D76-9BCF-397DE265F0FA

Q35185997-446DD294-1735-4C6D-8AAC-7C104A6D113A

Q35185997-50F7F929-8A0D-44DF-B77E-C060640AB2CB

Q35185997-540CC8DC-1782-470C-B92F-E1A62BEF339C

Q35185997-60465F77-B987-4E7B-86A1-33B41BDA3E4F

P304

Q35185997-56FDDDE3-5AE5-4283-93F9-A554166D2E58

P31

Q35185997-FADD7B75-7F34-441E-94AD-DFDD7116EF14

P356

Q35185997-622028BD-E8C8-483C-B5CB-17A875A44CF0

P407

Q35185997-EA2E7E06-050E-4437-931C-9A5F67F1437B

P433

Q35185997-A90B79F0-F0F4-43D4-87C2-B76AF64D8044

P478

Q35185997-E0FE6EFA-E9F2-4C95-8DAB-89D84C52EFDA

P50

Q35185997-CC0C9DC8-BB3C-47C6-A46B-D4C39F137D34

P577

Q35185997-9C0552C6-0649-40C1-820A-03815A992D7D

P5875

Q35185997-9E65CE4D-B596-435F-AA72-D57F54A57EDB

P698

Q35185997-1A76D911-6943-4DCB-82C6-DCBF057522C4

P932

Q35185997-55C66338-D591-4131-90CD-A5AEA822FF1C

P356

P1433

Journal of Virology

P1476

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies

@en

P2093

Anjali Nanda

http://www.w3.org/2001/XMLSchema#string

Bonnie A Ewald

http://www.w3.org/2001/XMLSchema#string

Diana M Lynch

http://www.w3.org/2001/XMLSchema#string

Jinyan Liu

http://www.w3.org/2001/XMLSchema#string

Shawn M Sumida

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a preventive vaccine for Ebola virus infection in primates

Phenotypic analysis of antigen-specific T lymphocytes

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.

Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys

Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity

Diversity considerations in HIV-1 vaccine selection.

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.

Prior vaccination increases the epitopic breadth of the cytotoxic T-lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infection.

Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice.

Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus.

P304

11991-11997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01348-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6788352

http://www.w3.org/2001/XMLSchema#string

P698

17005652

http://www.w3.org/2001/XMLSchema#string

P932

1676306

http://www.w3.org/2001/XMLSchema#string